Five percent (3/ 56) of patients without the YMDD variant and 13% (11/ 82) of patients with YMDD variant showed worsening in liver inflammation compared to pre-treatment.
Viiel protsendil (3/ 56) ilma YMDD variandita patsientidest ja 13% (11/ 82) YMDD variantse HBV- ga patsientidest tekkis haiguse süvenemine ravieelse seisundiga võrreldes.